Models of dengue virus infection

Drug Discovery Today: Disease Models

Volumn 3, Issue 1, 2006, Pages 97-103

  Bente, Dennis A ^a   Rico Hesse, Rebeca ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DENGUE VACCINE;

CHIMERA; COMBINED IMMUNODEFICIENCY; DENGUE; DISEASE SEVERITY; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MOLECULAR MECHANICS; MOSQUITO; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIMATE; REVIEW; TARGET CELL; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 33645891649     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.03.014     Document Type: Review

References (49)

1. World Health Organization (2002) Dengue/dengue hemorrhagic fever. Fact Sheet no. 117 (http://www.who.int/mediacentre/factsheets/fs117/en/)
2. Halstead S.B., et al. The future of dengue vaccines. Lancet 360 (2002) 1243-1245
3. Lambeth C.R., et al. Flow cytometry-based assay for titrating dengue virus. J. Clin. Microbiol. 43 (2005) 3267-3272
4. Cologna R., et al. Selection for virulent dengue viruses occurs in humans and mosquitoes. J. Virol. 79 (2005) 853-859
5. Cologna R., et al. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77 (2003) 3929-3938
6. Diamond M.S., et al. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol. 74 (2000) 4957-4966
7. Marovich M., et al. Human dendritic cells as targets of dengue virus infection. J. Investig. Dermatol. Symp. Proc. 6 (2001) 219-224
8. Dewi B.E., et al. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J. Virol. Methods 121 (2004) 171-180
9. Simmons J.S., et al. Experimental studies on dengue. Phillippine J. Sci. 44 (1931) 189-248
10. Rudnick A., et al. Possible jungle dengue - recent studies and hypotheses. Jpn. J. Med. Sci. Biol. 20 (1967) 69-74
11. Kilbourn A.M., et al. Health evaluation of free-ranging and semi-captive orangutans (Pongo pygmaeus pygmaeus) in Sabah, Malaysia. J. Wildl. Dis. 39 (2003) 73-83
12. Lavinder C.H., et al. The etiology of dengue. J. Infect. Dis. 15 (1914) 341-346
13. Blanc G., et al. Recherches experimentales sur la sensibilite des singes inferieurs au virus de la Dengue. Acad. Dermatol. Sci. 188 (1929) 468-470
14. Findlay G.M. The relation between dengue and rift valley fever. Trans. R. Soc. Trop. Med. Hyg. 26 (1932) 157-160
15. Dinger J.E., et al. Dengue und Gelbfieber. Arch. Schiffs Trop. Hyg. 35 (1931) 497-526
16. Halstead S.B., et al. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J. Infect. Dis. 128 (1973) 7-14
17. Rosen L. Experimental infection of New World monkeys with dengue and yellow fever viruses. Am. J. Trop. Med. Hyg. 7 (1958) 406-410
18. Scherer W.F., et al. Cross-protection studies and search for subclinical disease in new world monkeys infected sequentially with different immunologic types of dengue viruses. Am. J. Epidemiol. 95 (1972) 67-79
19. Schiavetta A.M., et al. Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virus. Contemp. Top Lab. Anim. Sci. 42 (2003) 12-20
20. Kochel T.J., et al. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J. Infect. Dis. 191 (2005) 1000-1004
21. Paul J.R., et al. Experimental attempts to transmit phlebotomus and dengue fever to chimpanzees. Proc. Soc. Exp. Biol. 68 (1948) 193-198
22. Scherer W.F., et al. Experimental infection of chimpanzees with dengue viruses. Am. J. Trop. Med. Hyg. 27 (1978) 590-599
23. Whitehead R.H., et al. Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am. J. Trop. Med. Hyg. 19 (1970) 94-102
24. Sabin A.B. Recent advances in our knowledge of dengue and sandfly fever. Am. J. Trop. Med. Hyg. 4 (1955) 198-207
25. Sabin A.B., et al. Production of immunity to dengue with virus modified by propagation in mice. Science 101 (1945) 640-642
26. Huang K.J., et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J. Gen. Virol. 81 Pt 9 (2000) 2177-2182
27. Shresta S., et al. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 319 (2004) 262-273
28. Johnson A.J., et al. New mouse model for dengue virus vaccine testing. J. Virol. 73 (1999) 783-786
29. Mosier D.E. Human xenograft models for virus infection. Virology 271 (2000) 215-219
30. Wu S.J., et al. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am. J. Trop. Med. Hyg. 52 (1995) 468-476
31. Lin Y.L., et al. Study of dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72 (1998) 9729-9737
32. An J., et al. Development of a novel mouse model for dengue virus infection. Virology 263 (1999) 70-77
33. Blaney Jr. J.E., et al. Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology 300 (2002) 125-139
34. Blaney Jr. J.E., et al. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J. Virol. 79 (2005) 5516-5528
35. Lin Y.L., et al. Infection of five human liver cell lines by dengue-2 virus. J. Med. Virol. 60 (2000) 425-431
36. Phoolcharoen W., et al. Internalization of the dengue virus is cell cycle modulated in HepG2, but not Vero cells. J. Med. Virol. 74 (2004) 434-441
37. Greiner D.L., et al. SCID mouse models of human stem cell engraftment. Stem Cells 16 (1998) 166-177
38. Serreze D.V., et al. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD × NON)F1 mice. Diabetes 37 (1988) 252-255
39. Meyerrose T.E., et al. Immune-deficient mouse models for analysis of human stem cells. Biotechniques 35 (2003) 1262-1272
40. Bunyaratvej A., et al. Dengue viruses induce cell proliferation and morphological changes of endothelial cells. Southeast Asian J. Trop. Med. Public Health 28 Suppl. 3 (1997) 32-37
41. Cravens P.D., et al. Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells 23 (2005) 264-278
42. Palucka A.K., et al. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood 102 (2003) 3302-3310
43. Bente D.A., et al. Dengue fever in humanized NOD/SCID mice. J. Virol. 79 (2005) 13797-13799
44. Worobey M., et al. Widespread intra-serotype recombination in natural populations of dengue virus. Proc. Natl. Acad. Sci. U S A 96 (1999) 7352-7357
45. Wang E., et al. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J. Virol. 74 (2000) 3227-3234
46. Carrington C.V., et al. Invasion and maintenance of dengue virus type 2 and type 4 in the Americas. J. Virol. 79 (2005) 14680-14687
47. Cummings D.A., et al. Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc. Natl. Acad. Sci. U S A 102 (2005) 15259-15264
48. Chadwick D., et al. Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis. J. Clin. Virol. 35 (2006) 147-153
49. Ibrahim F., et al. A novel dengue fever (DF) and dengue haemorrhagic fever (DHF) analysis using artificial neural network (ANN). Comput. Methods Programs Biomed. 79 (2005) 273-281